Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Cantor Fitzgerald
Fuji
Fish and Richardson
Medtronic
Federal Trade Commission
Cipla
Johnson and Johnson

Generated: November 14, 2018

DrugPatentWatch Database Preview

AURYXIA Drug Profile

« Back to Dashboard

Which patents cover Auryxia, and when can generic versions of Auryxia launch?

Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. There are fourteen patents protecting this drug.

The generic ingredient in AURYXIA is ferric citrate. There are eighteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ferric citrate profile page.

Drug patent expirations by year for AURYXIA
Generic Entry Opportunity Date for AURYXIA
Generic Entry Date for AURYXIA*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for AURYXIA
Synonyms for AURYXIA
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron salt
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron salt (1:?)
1,2,3-propanetricarboxylic acid, 2-hydroxy-, iron(2+) salt (2:3)
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt (1:1)
11084-12-1
1185-57-5
12386-83-3
12549-57-4
17217-76-4 (trihydrate)
2-hydroxy-1,2,3-propanetricarboxylic acid iron salt
2-hydroxypropane-1,2,3-tricarboxylate; iron(3+)
23087-37-8
2338-05-8
2338-05-8 (unspecified iron salt)
28633-45-6
28633-45-6 (unspecified iron(+3) salt)
3522-50-7
3522-50-7 (Parent)
3B1-003934
47516-89-2
57979-58-5 (dihydrate)
6043-74-9
62709-48-2
63G354M39Z
7705-15-9
A832727
AC1L1UYI
ACM28633456
AKOS015918266
AN-19905
C6H5FeO7
CCRIS 6843
Citric acid iron(III) salt
Citric acid, iron salt
Citric acid, iron(3+) salt
Citric acid, iron(3+) salt (1:1)
CTK1C2869
D04CJL
DB09162
DTXSID0037657
EINECS 222-536-6
EINECS 249-117-0
Fe(III)-citrate complex (1:1)
FERRIC CITRATE
Ferric citrate (VAN)
Ferric citrate [USAN]
FERRICCITRATE
ferrum citricum
FT-0626407
FT-0627304
FT-0652224
H260
Hyperphosphatemia therapy, Panion/Keryx
I14-60931
I14-8077
Iron (III) citrate
Iron 2-hydroxy-1,2,3-propanetricarboxylate
Iron citrate
Iron citrate, FeC6H5O7
Iron, (hydrogen citrato(3-))-
iron(3+) citrate
iron(3+) ion 2-hydroxypropane-1,2,3-tricarboxylate
iron(3+); 2-oxidanylpropane-1,2,3-tricarboxylate
Iron(III) citrate
Iron(III) citrate tribasic
Iron(III)-citrate
JTT 751
JTT-751
KRX-0502
KS-0000108D
MCULE-2140052675
Nephoxil
NPFOYSMITVOQOS-UHFFFAOYSA-K
NSC 112227
OR020149
OR253005
PBF-1681
SCHEMBL42945
TR-037246
TRA0022730
UNII-63G354M39Z
Zerenex

US Patents and Regulatory Information for AURYXIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Cantor Fitzgerald
Fuji
Fish and Richardson
Medtronic
Federal Trade Commission
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.